Company information
- Ticker
- EHAB
- Country
- United States
- Sector
- Health Care
- Industry
- Providers
Enhabit Business Summary
Enhabit, Inc. (EHAB) is a leading national provider of home health and hospice services, operating through two primary business segments: Home Health and Hospice. The company generates revenue primarily through Medicare-certified clinical services, including skilled nursing, physical and occupational therapy, and medical social work, as well as specialized hospice care focused on symptom management for life-limiting illnesses. As of February 2026, Enhabit operates approximately 249 home health and 117 hospice locations across 34 states. Following a period of strategic review, the company entered into a definitive agreement on February 23, 2026, to be acquired by private equity firm Kinderhook Industries for approximately $1.1 billion. In the competitive landscape, Enhabit contends with major players such as Addus HomeCare, The Pennant Group, and Amedisys; it maintains a significant market share as one of the largest independent providers in the space, though it has recently traded at a discount to peers due to leverage and margin pressures that precipitated its transition to private ownership. Enhabit was established as an independent public entity following its spin-off from Encompass Health Corporation in July 2022. The leadership team is currently headed by President and CEO Barb Jacobsmeyer, who brought over 30 years of healthcare experience from her previous role as Executive Vice President of Operations at Encompass Health. Supporting her is Chief Financial Officer Ryan Solomon, appointed in December 2024, who previously served as CFO for Aspirion and AccentCare. The company’s strategic direction is overseen by Chairman of the Board Jeffrey W. Bolton, a veteran healthcare executive. Notable board members include corporate governance expert Charles M. Elson and former Brookdale Senior Living executive Mark W. Ohlendorf. While the company is currently transitioning to ownership by Kinderhook Industries, it has historically maintained high institutional backing from firms like BlackRock and Vanguard, reflecting its established position within the post-acute care infrastructure.